Global Cell Line Engineering Services Market Growth (Status and Outlook) 2025-2031

The global Cell Line Engineering Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Cell line engineering services is a biotechnology service that utilizes gene editing and cell culture technologies to edit and modify cells for various research and application needs. In this service, professional scientists design suitable gene editing schemes based on the customer"s requirements and use gene editing tools such as CRISPR/Cas9 to precisely modify, insert, or delete the target gene sequence. Through specific cell culture techniques, the modified cells can obtain superior phenotypes and characteristics, such as higher product yield, better growth characteristics, and higher immune response.

Cell line engineering services are mainly applied in the field of biomedicine, such as drug screening, immunotherapy, gene therapy, etc. Furthermore, since this technology can be applied to various types of cells and animal and plant cells, it can also be applied in fields such as food and agriculture, such as improving the disease resistance of some plants and improving the quality of certain meat products.

United States market for Cell Line Engineering Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cell Line Engineering Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cell Line Engineering Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cell Line Engineering Services players cover CD BioSciences, Curia, Horizo​​n Discovery, Multispan, Inc., System Biosciences (SBI), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cell Line Engineering Services Industry Forecast” looks at past sales and reviews total world Cell Line Engineering Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Line Engineering Services sales for 2025 through 2031. With Cell Line Engineering Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line Engineering Services industry.

This Insight Report provides a comprehensive analysis of the global Cell Line Engineering Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Line Engineering Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Engineering Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Engineering Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Engineering Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Engineering Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

Small scale

Medium scale

Large scale

Segmentation by Application:

Bio-pharmaceutical

Medical Treatment

Medical Research

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

CD BioSciences

Curia

Horizo​​n Discovery

Multispan, Inc.

System Biosciences (SBI)

Biocon

Cyagen

Analytical Biological Services (ABS)

Celvab

Boston Institute of Biotechnology

ALSTEM

ProMab Biotechnologies

Cytosurge AG

Merck

Thermo Fisher Scientific

WuXi Advanced Therapies

GenScript Biotech Corporation (HK.1548)

Please note: The report will take approximately 2 business days to prepare and deliver.